Hetero Hyderabad Walk-in Interview Freshers for QA/QC, Production, Maintenance
- Hetero Hyderabad Walk-in Interview 2024: QA, QC, Production, Maintenance Roles for Freshers
- Available Roles:
- Eligibility Criteria:
- Hetero Hyderabad Interview Details:
Hetero Hyderabad Walk-in Interview 2024: QA, QC, Production, Maintenance Roles for Freshers
Are you a recent graduate looking to kickstart your career in the pharmaceutical industry? Hetero invites talented individuals for a walk-in interview at its Hyderabad office on 19th May 2024. This is your chance to join a leading pharmaceutical company and grow professionally in roles such as QA/QC, Production, and Maintenance. Read on to discover more about these exciting opportunities and how you can be part of Hetero success story.
About Hetero: Hetero is a renowned name in the pharmaceutical industry, known for its commitment to quality and innovation. With a strong presence in Hyderabad, Hetero offers a dynamic work environment where freshers can thrive and contribute to groundbreaking projects.
Available Roles:
- QA,
- QC: Suitable for MSc Chemistry graduates with a passion for quality assurance and control.
- Production: Opportunities for BSc Chemistry graduates with expertise in organic, inorganic, analytical, applied, or integrated production processes.
- Maintenance: Ideal for ITI fitters and Diploma Mechanical graduates interested in equipment maintenance and upkeep.
Eligibility Criteria:
If you graduated in 2020, 2021, 2022, 2023, or 2024, you are eligible to participate in this walk-in interview. Bring your updated resume and academic documents to showcase your qualifications and skills.
Hetero Hyderabad Interview Details:
- Date: 19th May 2024
- Time: 9.00 a.m. to 12.00 p.m.
- Venue: Hetero Corporate Office, 7-2-A2, Hetero Corporate Industrial Estates, SanathNagar, Hyderabad – 500 018, Telangana, INDIA.
Don’t miss this opportunity to launch your career with Hetero. Join us at the walk-in interview and take the first step towards a rewarding future in the pharmaceutical industry.
Responses